Shockwave Medical Inc. Stock News

ShockWave Medical (SWAV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

After reaching an important support level, Shockwave Medical (SWAV) could be a good stock pick from a technical perspective. SWAV surpassed resistance at the 20-day moving average, suggesting a short-

SANTA CLARA, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment car

Shockwave Medical just got a boost from a Medicare decision on one of its products. Bio-Techne is benefiting from increased cell and gene therapy revenue.

The healthcare sector has underperformed this year, with the Health Care Select Sector SPDR (NYSEARCA: XLV ) down 1%. After a disappointing year-to-date performance, it's time to consider some top hea

SANTA CLARA, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment car

SoFi Technologies is an all-digital bank with a rapidly growing base of members and deposits. Shockwave Medical makes intravenous lithotripsy devices that reduce the risk of life-threatening complicat

Wegovy and Mounjaro obesity and diabetes drugs are expected to have a significant impact on society and may lead to a decrease in demand for certain medical devices and surgeries. Medical device stock

With various scenarios, these top-rated stocks are appealing after reporting their Q2 results on Monday and should have more upside as we progress through 2023.

Shockwave Medical Inc. is a medical device developer focusing on calcified cardiovascular disease treatments, with a promising market opportunity. SWAV recently completed the acquisition of Neovasc In

Shockwave Medical's (SWAV) second-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.

Shockwave Medical's Q2 results exceeded revenue expectations but fell short on earnings. The bottom-line shortfall came amid acquisition expenses and headcount expansion to support growth.

Shockwave Medical (SWAV) came out with quarterly earnings of $0.76 per share, missing the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $0.68 per share a year ago.

SANTA CLARA, Calif., July 18, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment car

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.